Titan Medical Inc
TSX:TMD

Watchlist Manager
Titan Medical Inc Logo
Titan Medical Inc
TSX:TMD
Watchlist
Price: 0.045 CAD 2 268.42% Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Titan Medical Inc?
Write Note

Titan Medical Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Titan Medical Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Titan Medical Inc
TSX:TMD
Additional Paid In Capital
$25.2m
CAGR 3-Years
30%
CAGR 5-Years
27%
CAGR 10-Years
25%
Profound Medical Corp
TSX:PRN
Additional Paid In Capital
$20.1m
CAGR 3-Years
14%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Opsens Inc
TSX:OPS
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanalysis Scientific Corp
XTSX:NSCI
Additional Paid In Capital
CA$4.7m
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theralase Technologies Inc
XTSX:TLT
Additional Paid In Capital
CA$13.3m
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
12%
MedMira Inc
XTSX:MIR
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Titan Medical Inc
Glance View

Market Cap
1.1B CAD
Industry
Health Care

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). The company is headquartered in Toronto, Ontario and currently employs 49 full-time employees. The company went IPO on 2008-04-28. The firm is developing its Enos system to become the new standard of care in robotic single access surgery, with dual three-dimensional (3D) and two-dimensional (2D) high-definition vision systems, multi-articulating instruments and an ergonomic surgeon workstation. Its multi-articulated instruments bring fluid to position the effectors for grasping, suturing, cutting and coagulation. The Enos surgeon workstation includes a 3D high-definition display to provide a balance of surgical immersion and situational awareness in the operating room.

TMD Intrinsic Value
0.003 CAD
Overvaluation 93%
Intrinsic Value
Price

See Also

What is Titan Medical Inc's Additional Paid In Capital?
Additional Paid In Capital
25.2m USD

Based on the financial report for Jun 30, 2024, Titan Medical Inc's Additional Paid In Capital amounts to 25.2m USD.

What is Titan Medical Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
25%

Over the last year, the Additional Paid In Capital growth was -2%. The average annual Additional Paid In Capital growth rates for Titan Medical Inc have been 30% over the past three years , 27% over the past five years , and 25% over the past ten years .

Back to Top